SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shalini Agnihotri, Rama Devi Mittal, Rakesh Kapoor, Anil Mandhani, Asymptomatic prostatic inflammation in men with clinical BPH and erectile dysfunction affects the positive predictive value of prostate-specific antigen, Urologic Oncology: Seminars and Original Investigations, 2014,

    CrossRef

  2. 2
    Liz Forbat, Morag Place, Gill Hubbard, Hing Leung, Daniel Kelly, The role of interpersonal relationships in men's attendance in primary care: qualitative findings in a cohort of men with prostate cancer, Supportive Care in Cancer, 2014, 22, 2, 409

    CrossRef

  3. 3
    Liz Forbat, Morag Place, Daniel Kelly, Gill Hubbard, Kenny Boyd, Kate Howie, Hing Y. Leung, A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing, BJU International, 2013, 111, 3
  4. 4
    Jong Jin Oh, Seong Jin Jeong, Chang Wook Jeong, Seok-Soo Byun, Sung Kyu Hong, Gheeyoung Choe, Sang Eun Lee, Is there any association between the severity of lower urinary tract symptoms and the risk of biopsy-detectable prostate cancer in patients with PSA level below 20 ng/ml in multi-core prostate biopsy?, The Prostate, 2013, 73, 1
  5. 5
    Dong Soo Park, Jong Jin Oh, Jae Yup Hong, Young Kwon Hong, Don Kyung Choi, In Hyuck Gong, Jin Ho Hwang, Sung Won Kwon, Serum prostate-specific antigen as a predictor of prostate volume and lower urinary tract symptoms in a community-based cohort: a large-scale Korean screening study, Asian Journal of Andrology, 2013, 15, 2, 249

    CrossRef

  6. 6
    Jon D. Emery, Katie Shaw, Briony Williams, Danielle Mazza, Julia Fallon-Ferguson, Megan Varlow, Lyndal J. Trevena, The role of primary care in early detection and follow-up of cancer, Nature Reviews Clinical Oncology, 2013, 11, 1, 38

    CrossRef

  7. 7
    Maria Frånlund, Sigrid Carlsson, Johan Stranne, Gunnar Aus, Jonas Hugosson, The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial, BJU International, 2012, 110, 5
  8. 8
    Naomi Williams, Laura J. Hughes, Emma L. Turner, Jenny L. Donovan, Freddie C. Hamdy, David E. Neal, Richard M. Martin, Chris Metcalfe, Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities, BJU International, 2011, 108, 9
  9. 9
    Christian T. Brown, Mark Emberton, Self-management for men with lower urinary tract symptoms, Current Urology Reports, 2009, 10, 4, 261

    CrossRef

  10. 10
    Christian T. Brown, Mark Emberton, Self-management for men with lower urinary tract symptoms, Current Prostate Reports, 2009, 7, 3, 111

    CrossRef

  11. 11
    Simon M. Collin, Chris Metcalfe, Jenny Donovan, J. Athene Lane, Michael Davis, David Neal, Freddie Hamdy, Richard M. Martin, Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study, BJU International, 2008, 102, 10
  12. 12
    Richard M. Martin, Lars Vatten, David Gunnell, Pål Romundstad, Tom I.L. Nilsen, Lower urinary tract symptoms and risk of prostate cancer: The HUNT 2 Cohort, Norway, International Journal of Cancer, 2008, 123, 8
  13. 13
    Hideki Kanda, Kenichiro Ishii, Yuji Ogura, Tetsuya Imamura, Masahiro Kanai, Kiminobu Arima, Yoshiki Sugimura, Naftopidil, a selective α-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest, International Journal of Cancer, 2008, 122, 2
  14. 14
    N S Awsare, J S A Green, B Aldwinckle, D C Hanbury, G B Boustead, T A McNicholas, The measurement of psychological distress in men being investigated for the presence of prostate cancer, Prostate Cancer and Prostatic Diseases, 2008, 11, 4, 384

    CrossRef

  15. 15
    Chris Metcalfe, Biral Patel, Simon Evans, Fowzia Ibrahim, Ken Anson, Francis Chinegwundoh, Cathy Corbishley, Danny Dorling, Bethan Thomas, David Gillatt, Roger Kirby, Gordon Muir, Vinod Nargund, Rick Popert, Raj Persad, Yoav Ben-Shlomo, The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study, BJU International, 2008, 102, 10
  16. 16
    N J Rukin, M P Zeegers, S Ramachandran, C J Luscombe, S Liu, M Saxby, J Lear, R C Strange, A comparison of sunlight exposure in men with prostate cancer and basal cell carcinoma, British Journal of Cancer, 2007, 96, 3, 523

    CrossRef

  17. 17
    Sam Moon, Sarah Holley, Dhaval Bodiwala, Christopher J. Luscombe, Michael E. French, Samson Liu, Mark F. Saxby, Peter W. Jones, Anthony A. Fryer, Richard C. Strange, Associations Between G/A1229, A/G3944, T/C30875, C/T48200 and C/T65013 Genotypes and Haplotypes in the Vitamin D Receptor Gene, Ultraviolet Radiation and Susceptibility to Prostate Cancer, Annals of Human Genetics, 2006, 70, 2
  18. 18
    John Oliffe, Being Screened for Prostate Cancer, Cancer Nursing, 2006, 29, 1, 1

    CrossRef

  19. You have free access to this content19
    AKIO MATSUBARA, HIROAKI YASUMOTO, JUN TEISHIMA, MITSUHIRO SEKI, KOJI MITA, YASUHISA HASEGAWA, TATEKI YOSHINO, MASAO KATO, TSUGURU USUI, Lower urinary tract symptoms and risk of prostate cancer in Japanese men, International Journal of Urology, 2006, 13, 8
  20. 20
    Lucy A. Brindle, Steven E. Oliver, Daniel Dedman, Jenny L. Donovan, David E. Neal, Freddie C. Hamdy, Janet A. Lane, Tim J. Peters, Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK, BJU International, 2006, 98, 4
  21. 21
    René Wolters, Michel Wensing, Maarten Klomp, Toine Lagro-Jansen, Chris van Weel, Richard Grol, Effects of distance learning on clinical management of LUTS in primary care: a randomised trial, Patient Education and Counseling, 2005, 59, 2, 212

    CrossRef

  22. 22
    Mary McNaughton-Collins, Michael J. Barry, Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia, The American Journal of Medicine, 2005, 118, 12, 1331

    CrossRef

  23. 23
    R. J. Wolters, Mictieklachten bij oudere mannen: luts, Bijblijven, 2005, 21, 5, 188

    CrossRef

  24. 24
    Samuel J. Moon, Anthony A. Fryer, Richard C. Strange, Ultraviolet Radiation, Vitamin D and Risk of Prostate Cancer and Other Diseases, Photochemistry and Photobiology, 2005, 81, 6
  25. 25
    Melina Gattellari, Jeanette E. Ward, A community study using specified and unspecified scenarios to investigate men's views about PSA screening, Health Expectations, 2004, 7, 4
  26. 26
    Christian T Brown, Mark Emberton, Could self-management challenge pharmacotherapy as a long-term treatment for uncomplicated lower urinary tract symptoms?, Current Opinion in Urology, 2004, 14, 1, 7

    CrossRef

  27. 27
    Dhaval Bodiwala, Christopher J. Luscombe, Michael E. French, Samson Liu, Mark F. Saxby, Peter W. Jones, Anthony A. Fryer, Richard C. Strange, Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer, Environmental and Molecular Mutagenesis, 2004, 43, 2
  28. 28
    M. Gattellari, J. M Young, J. E Ward, GP and patient predictors of PSA screening in Australian general practice, Family Practice, 2003, 20, 3, 294

    CrossRef

  29. 29
    Jane M. Young, Michael J. Solomon, Improving the evidence base in surgery: sources of bias in surgical studies, ANZ Journal of Surgery, 2003, 73, 7
  30. 30
    C.T. Brown, J. Van Der Meulen, A.R. Mundy, M. Emberton, Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey, BJU International, 2003, 92, 1
  31. 31
    C.T. Brown, E. O'Flynn, J. Van Der Meulen, S. Newman, A.R. Mundy, M. Emberton, The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened?, BJU International, 2003, 91, 1
  32. 32
    Christopher J Luscombe, Michael E French, Samson Liu, Mark F Saxby, William E Farrell, Peter W Jones, Anthony A Fryer, Richard C Strange, Glutathione S-transferase GSTP1 genotypes are associated with response to androgen ablation therapy in advanced prostate cancer, Cancer Detection and Prevention, 2002, 26, 5, 376

    CrossRef

  33. 33
    S. Sriprasad, P. M. Thompson, Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence, BJU International, 2001, 87, 1